285
Views
10
CrossRef citations to date
0
Altmetric
Review Article

Highlights of human ectopic fascioliasis: a systematic review

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 785-792 | Received 13 Jun 2019, Accepted 28 Aug 2019, Published online: 11 Sep 2019

References

  • Mas-Coma S, Bargues MD, Valero M. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005;35(11–12):1255–1278.
  • Molloy J, Anderson G. The distribution of Fasciola hepatica in Queensland, Australia, and the potential impact of introduced snail intermediate hosts. Vet Parasitol. 2006;137(1–2):62–66.
  • Fürst T, Duthaler U, Sripa B. Trematode infections: liver and lung flukes. Infect Dis Clin. 2012;26:399–419.
  • Park CI, Kim H, Ro JY, et al. Human ectopic fascioliasis in the cecum. Am J Surg Pathol. 1984;8(1):73–77.
  • Prociv P, Walker J, Whitby M. Human ectopic fascioliasis in Australia: first case reports. Med J Australia. 1992;156:349–351.
  • Vatsal DK, Kapoor S, Venkatesh V, et al. Ectopic fascioliasis in the dorsal spine: case report. Neurosurgery. 2006;59(3):E706–707.
  • Chang E-C, Choi H-L, Park Y-W, et al. Subcutaneous fascioliasis: a case report. Kisaengchunghak Chapchi. 1991;29(4):403–405.
  • Zhou L, Luo L, You C, et al. Multiple brain hemorrhages and hematomas associated with ectopic fascioliasis in brain and eye. Surg Neurol. 2008;69(5):516–521.
  • Fazlipour A, Ranjbari N, Eslami N, et al. Fasciola hepatica as a neck mass. Pharmacophore. 2017;8(6S):e-1173306.
  • Yi-Zhu X, Zhi-Bang Y. A case of ectopic fascioliasis in the skin. Trop Doct. 2010;40(4):253–254.
  • Nithiuthai S, Anantaphruti MT, Waikagul J, et al. Waterborne zoonotic helminthiases. Vet Parasitol. 2004;126(1–2):167–193.
  • Mas-Coma M, Esteban J, Bargues M. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ. 1999;77(4):340.
  • Soliman MF. Epidemiological review of human and animal fascioliasis in Egypt. J Infect Dev Ctries. 2008;2(03):182–189.
  • Curtale F, El‐Wahab Hassanein YA, et al. Distribution of human fascioliasis by age and gender among rural population in the Nile Delta, Egypt. J Trop Pediatr. 2003;49(5):264–268.
  • Ashrafi K, Valero MA, Peixoto RV, et al. Distribution of Fasciola hepatica and F. gigantica in the endemic area of Guilan, Iran: relationships between zonal overlap and phenotypic traits. Infect Genet Evol. 2015;31:95–109.
  • World Health Organization. Control of foodborne trematode infections: report of a WHO study group. 1995.
  • Daumerie D, Savioli L. Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. World Health Organization. 2010. Vol. 1. p. 1–172.
  • Chen M, Mott K. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull. 1990;87(4):1–38.
  • Esteban J-G, Flores A, Aguirre C, et al. Presence of very high prevalence and intensity of infection with Fasciola hepatica among Aymara children from the Northern Bolivian Altiplano. Acta Tropica. 1997;66(1):1–14.
  • Trueba G, Guerrero T, Fornasini M, et al. Detection of Fasciola hepatica infection in a community located in the Ecuadorian Andes. Am J Trop Med Hygiene. 2000;62(4):518–518.
  • El-Karaksy H, Hassanein B, Okasha S, et al. Human fascioliasis in Egyptian children: successful treatment with triclabendazole. J Trop Pediatr. 1999;45(3):135–138.
  • Marcos L, Maco V, Terashima A, et al. Fascioliasis in relatives of patients with Fasciola hepatica infection in Peru. Rev Inst Med Trop S Paulo. 2005;47(4):219–222.
  • Hezam K, Morshed AF, Hassan A, et al. Prevalence of parasitic helminthes among slaughtered animals in slaughterhouses in Taiz, Yemen. Int J Curr Microbiol App Sci. 2016;5(8):80–88.
  • Massoud J. Fascioliasis outbreak of man and drug test (Triclabendazol) in Caspian littoral, northern part of Iran, 1989. Bull Soc Fr Parasitol. 1990;8:438.
  • Cywińska A. Epidemiology of fascioliasis in human endemic areas. J Helminthol. 2005;79:207–216.
  • Ashrafi K, Saadat F, O'Neill S, et al. The endemicity of human fascioliasis in Guilan province, northern Iran: the baseline for implementation of control strategies. Iranian J Public Health. 2015;44(4):501.
  • Ashrafi K, Bargues MD, O'Neill S, et al. Fascioliasis: a worldwide parasitic disease of importance in travel medicine. Travel Med Infect Dis. 2014;12(6):636–649.
  • Hotez PJ, Savioli L, Fenwick A. Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis. 2012;6(2):e1475.
  • Tolan RW. Jr. Fascioliasis due to Fasciola hepatica and Fasciola gigantica infection: an update on this ‘neglected’ neglected tropical disease. Lab Med. 2011;42(2):107–116.
  • Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(3):210–221.
  • Robinson MW, Dalton JP. Zoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases. Phil Trans R Soc B. 2009;364(1530):2763.
  • Ying M, Xiaosu H, Wang B. A case of ectopic parasitism: Fasciola hepatica larvae burrow through a human brain and mimic cerebral aneurysm. Trans Royal Soc Trop Med Hygiene. 2007;101(10):1051–1052.
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
  • Dowlati Y, Dowlati A, Seyyedi B. Cutaneous fascioliasis. Med J Islam Republic Iran. 1987; 1:62–65.
  • Le Thi X, Hung NT, Waikagul J. Cutaneous fascioliasis: a case report in Vietnam. Am J Trop Med Hygiene. 2005;72:508–509.
  • Emami Al-Agha M, Athari A. Subcutaneous fascioliasis: a rare complication. Med J Islam Repub Iran (MJIRI). 1995;8:269–270.
  • Dalimi A, Jabarvand M. Fasciola hepatica in the human eye. Trans R Soc Trop Med Hygiene. 2005;99(10):798–800.
  • Cho S-Y, Yang HN, Kong Y, et al. Intraocular fascioliasis: a case report. Am J Trop Med Hygiene. 1994;50(3):349–353.
  • Ruggieri F, Correa AJ, Martinez E. Cerebral distomiasis: case report. J Neurosurg. 1967;27(3):268–271.
  • Lee SH, Cho SY, Seo BS, et al. A human case of ectopic fascioliasis in Korea. Kisaengchunghak Chapchi. 1982;20(2):191–200.
  • Makay O, Gurcu B, Caliskan C, et al. Ectopic fascioliasis mimicking a colon tumor. World J Gastroenterol. 2007;13(17):2633.
  • Öngören AU, Özkan AT, Demirel AH, et al. Ectopic intra-abdominal fascioliasis. Turk J Med Sci. 2009;39:819–823.
  • Kim AJ, Choi CH, Choi SK, et al. Ectopic human Fasciola hepatica infection by an adult worm in the mesocolon. Korean J Parasitol. 2015;53(6):725.
  • Özkan AT. A case of ectopic intraabdominal fascioliasis presented with acute abdomen. Turk J Gastroenterol. 2011; 22:347–350.
  • Echenique-Elizondo M, Amondarain J, Lirón de Robles C. Fascioliasis: an exceptional cause of acute pancreatitis. J Pancreas. 2005;6(1):36–39.
  • Fujita S, Beppu M, Haku K. A case report of fascioliasis in the pancreas preoperatively diagnosed as cystadenocarcinoma by endoscopic retrograde pancreatography. Jpn J Gastroenterol Surg. 1991;24(5):1305–1308.
  • Parsak C, Koltas I, Sakman G, et al. Surgery in Fasciola hepatica pancreatitis: report of a case and review of literature. Z Gastroenterol. 2007;45(4):313–316.
  • Marcos LA, Légua P, Sánchez J, et al. Cervical tumor caused by the sexually mature stage of Fasciola hepatica. Trans Royal Soc Trop Med Hygiene. 2009;103(3):318–320.
  • Mohammadi-Ghalehbin B, Chinifroush-Asl MM, Ramzi F. Extra-hepatic fascioliasis with peritoneal malignancy tumor feature. J Parasit Dis. 2012;36(1):78–80.
  • Musa D, Godbole G, Chiodini PL, et al. Unusual case of a lung abscess. BMJ Case Rep. 2013;2013(Apr16 1):bcr2012008306.
  • Sabourin E, Alda P, Vázquez A, et al. Impact of human activities on fasciolosis transmission. Trends Parasitol. 2018;34(10):891–903.
  • Ashrafi K, Massoud J, Holakouei K, et al. Evidence suggesting that Fasciola gigantica might be the most prevalent causal agent of fascioliasis in northern Iran. Iranian J Public Health. 2004;33:31–37.
  • Marcos L, Maco V, Samalvides F, et al. Risk factors for Fasciola hepatica infection in children: a case–control study. Trans Royal Soc Trop Med Hygiene. 2006;100(2):158–166.
  • Ashrafi K. The status of human and animal fascioliasis in Iran: a narrative review article. Iranian J Parasitol. 2015;10(3):306.
  • Esteban J-G, Gonzalez C, Curtale F, et al. Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt. Am J Trop Med Hygiene. 2003;69(4):429–437.
  • Esteban JG, González C, Bargues MD, et al. High fascioliasis infection in children linked to a man‐made irrigation zone in Peru. Trop Med Int Health. 2002;7:339–348.
  • Dobrucali A, Yigitbasi R, Erzin Y, et al. Fasciola hepatica infestation as a very rare cause of extrahepatic cholestasis. WJG. 2004;10(20):3076.
  • Valero MA, Santana M, Morales M, et al. Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model. J Infect Dis. 2003;188(5):787–793.
  • Teichmann D, Grobusch MP, Göbels K, et al. Acute fascioliasis with multiple liver abscesses. Scand J Infect Dis. 2000;32(5):558–560.
  • Tsocheva-Gaytandzhieva N. Fasciolosis and tumour growth. Helminthologia. 2005;42:107.
  • Chernecky CC, Berger BJ. Laboratory tests and diagnostic procedures. Amsterdam: Elsevier Health Sciences; 2007.
  • Garcia LS. Diagnostic medical parasitology. Washington DC, USA: American Society for Microbiology Press; 2006.
  • Mas-Coma S, Bargues M, Valero M. Diagnosis of human fascioliasis by stool and blood techniques: update for the present global scenario. Parasitology. 2014;141(14):1918–1946.
  • Salimi-Bejestani M, McGarry J, Felstead S, et al. Development of an antibody-detection ELISA for Fasciola hepatica and its evaluation against a commercially available test. Res Veter Sci. 2005;78(2):177–181.
  • Rokni MB, Massoud J, O’Neill SM, et al. Diagnosis of human fasciolosis in the Gilan province of Northern Iran: application of cathepsin L-ELISA. Diagnos Microbiol Infect Dis. 2002;44(2):175–179.
  • Kabaalioğlu A, Cubuk M, Senol U, et al. Fascioliasis: US, CT, and MRI findings with new observations. Abdominal Imaging. 2000;25(4):400–404.
  • Dusak A, Onur MR, Cicek M, et al. Radiological imaging features of Fasciola hepatica infection–a pictorial review. J Clin Imaging Sci. 2012;2:2–8.
  • Zali MR, Ghaziani T, Shahraz S, et al. Liver, spleen, pancreas and kidney involvement by human fascioliasis: imaging findings. BMC Gastroenterol. 2004;4(1):15.
  • Saba R, Korkmaz M. Human fascioliasis. Clin Microbiol Newslett. 2005;27(4):27–34.
  • Lee OJ, Kim TH. Indirect evidence of ectopic pancreatic fascioliasis in a human. J Gastroenterol Hepatol. 2006;21(10):1631–1633.
  • Machicado C, Machicado JD, Maco V, et al. Association of Fasciola hepatica infection with liver fibrosis, cirrhosis, and cancer: a systematic review. PLoS Negl Trop Dis. 2016;10(9):e0004962.
  • World Health Organization. WHO model prescribing information: drugs used in parasitic diseases. 1995.
  • Graham CS, Brodie SB, Weller PF. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole. Clin Infect Dis. 2001;33(1):1–5.
  • Llanos C, Soto L, Sabugo F, et al. Systemic vasculitis associated with Fasciola hepatica infection. Scand J Rheumatol. 2006;35(2):143–146.
  • Mas-Coma S, Agramunt VH, Valero MA. Neurological and ocular fascioliasis in humans. Adv Parasitol. 2014;84:27–149.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.